_________
false
פלוריסטם תרפיוטיקס אינק
2
381
PLURISTEM THERAPEUTICS INC
Corporation no:
C12337-2001
8544
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
17/07/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-061734
Time of broadcast:
13:53
13:27:48
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Pluristem and U.S. Department of Defense to Announce Data from Studies Testing PLX-R18 as a Prophylactic Treatment for Acute Radiation Syndrome at RITN
Pluristem_DoD_R18_pre_conference_FINAL_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
25/06/2019
Address:
Matam Park
5
,
Haifa
31905
ISRAEL
,
Tel:
074-7107171
,
Fax:
074-7107172
E-mail address:
Info@Pluristem.Com
Company site:
www.pluristem.com
Previous names of reporting entity:
Name of the Signatory:
Aberman Zalman
Position of Signatory in the reporting corporation:
Chairman Of The Board & CEO
Name of Employer Company:
Address:
Matam Park
20
,
Haifa
31905
Telephone:
074-7107171
Facsimile:
074-7107172
E-mail:
zami@pluristem.com
2